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Abstract
Background: Implementing evidence-based practices (EBPs) to increase cancer screenings in safety net primary
care systems has great potential for reducing cancer disparities. Yet there is a gap in understanding the factors and
mechanisms that influence EBP implementation within these high-priority systems. Guided by the Consolidated
Framework for Implementation Research (CFIR), our study aims to fill this gap with a multiple case study of health
care safety net systems that were funded by an American Cancer Society (ACS) grants program to increase breast
and colorectal cancer screening rates. The initiative funded 68 safety net systems to increase cancer screening
through implementation of evidence-based provider and client-oriented strategies.
Methods: Data are from a mixed-methods evaluation with nine purposively selected safety net systems. Fifty-two
interviews were conducted with project leaders, implementers, and ACS staff. Funded safety net systems were
categorized into high-, medium-, and low-performing cases based on the level of EBP implementation. Within- and
cross-case analyses were performed to identify CFIR constructs that influenced level of EBP implementation.
Results: Of 39 CFIR constructs examined, six distinguished levels of implementation. Two constructs were from the
intervention characteristics domain: adaptability and trialability. Three were from the inner setting domain:
leadership engagement, tension for change, and access to information and knowledge. Engaging formally appointed
internal implementation leaders, from the process domain, also distinguished level of implementation. No constructs
from the outer setting or individual characteristics domain differentiated systems by level of implementation.
Conclusions: Our study identified a number of influential CFIR constructs and illustrated how they impacted EBP
implementation across a variety of safety net systems. Findings may inform future dissemination efforts of EBPs for
increasing cancer screening in similar settings. Moreover, our analytic approach is similar to previous case studies using
CFIR and hence could facilitate comparisons across studies.
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Background
Although cancer mortality rates in the USA have been
declining, significant disparities persist, especially by
race/ethnicity and socio-economic status [1–3]. Unfortu-
nately, disparities also exist in early detection through
cancer screening [3–5]. The persistence of these dispar-
ities warrants targeted efforts to employ evidence-based
practices (EBPs) within settings that reach populations
experiencing a disproportionate share of the cancer bur-
den. Evidence-based guidelines for promoting cancer
screening include the Guide to Community Preventive
Services which recommends both client- and provider-
oriented approaches to increase screening rates [6]. As
in many areas of health care, however, there is a gap be-
tween evidence-based guidelines and actual practice [7].
In safety net health care systems, which include public
hospitals, federally-funded community health centers
and Federally Qualified Health Centers (FQHCs), local
health department clinics, and free clinics that provide
care for low-income, uninsured and vulnerable patients,
this gap may be particularly wide. In community health
centers, a centerpiece of the nation’s health care safety
net, less than 35 % of patients aged 51 to 74 had been ap-
propriately screened for colorectal cancer (CRC) in 2014;
in contrast, 65.1 % of the general population in this age
group was current on CRC screening in 2012 [4, 8].
Numerous theories and models have been proposed to
inform and study the adoption and implementation of in-
novations, including evidence-based interventions such as
recommendations to increase cancer screening [9–12].
The Consolidated Framework for Implementation Re-
search (CFIR) attempts to advance our understanding of
implementation across a range of settings and types of in-
terventions by synthesizing and categorizing constructs
across different theories and models [13]. The CFIR orga-
nizes 39 constructs and sub-constructs within five major
domains: intervention characteristics, outer setting, inner
setting, characteristics of the individuals involved, and the
process of implementation. Much of the research using
CFIR to date has been qualitative [14–21]. Some studies
were intentionally designed to examine CFIR constructs
[19] and others organized emerging themes using CFIR
categories following data collection [22–24]. Damschroder
and Lowery recently illustrated a methodology for using
CFIR to qualitatively identify constructs that differentiate
levels of implementation [14]. This or similar method-
ology has been used to examine implementation in several
recent studies [14, 25, 26].
Relatively few studies have examined implementation
of EBPs to increase cancer screening. A recent study
used CFIR before actual implementation to inform the
adaptation of an evidence-based program promoting
CRC screening in a FQHC [7]. A second qualitative
study of factors influencing cancer prevention in FQHCs
did not use a conceptual model per se but identified
competing priorities (e.g., medical home transformation),
lack of reimbursement, and insufficient patient insurance
as barriers to screening [27]. Federal reporting require-
ments were seen as a facilitator to improved cancer
prevention and control. Neither of these studies identi-
fied factors that distinguished levels of implementation
of EBPs for cancer screening.
The current study aims to fill such gaps by using CFIR to
conduct a secondary analysis of data collected from an ini-
tiative to increase cancer screening in safety net settings.
Understanding barriers and facilitators to cancer screening
in settings that serve patients with significant health dispar-
ities is an important step in identifying strategies to de-
crease these disparities. Given persistent health disparities
in cancer and the importance of accelerating adoption of
EBPs to promote cancer screening, the American Cancer
Society (ACS) developed the Community Health Initiatives:
Community Health Advocates Implementing Nationwide
Grants for Empowerment and Equity (CHANGE grants)
program. This program funds primary care systems, with
an emphasis on safety net providers, to implement EBPs to
increase breast and/or colorectal cancer screening. Many of
the grantees were FQHCs or FQHC look-alikes; the latter
are certified as meeting federal health center requirements
but are not part of the same funding stream. Through con-
ducting a secondary analysis of data collected as part of an
evaluation of the ACS’s Community Health Initiatives
CHANGE Grants program, the current study aims to iden-
tify factors that distinguished implementation performance





The ACS CHANGE Grants program promotes EBPs for
cancer screening as recommended by the US Community
Preventive Services Task Force [6] and the National
Colorectal Cancer Roundtable [28]. Recommended client-
oriented strategies include client reminders, small media,
group education, one-on-one education, reduction of struc-
tural barriers, and reduction of out-of-pocket costs.
Provider-oriented strategies include provider assessment
and feedback, and provider reminder and recall systems.
Grants in 2013 ranged from $40,000 to $80,000, with the
majority funded at $50,000.
Study sample
Of the 68 grant recipients of the CHANGE program in
2013, nine health systems were selected for site visits. To
maximize variation, systems were chosen based on level of
implementation as indicated in interim progress reports,
cancer site (breast vs. colorectal), priority population (e.g.,
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race/ethnicity), geographic location, and corporate fun-
ders. Qualitative data were collected during site visits con-
ducted 7–8 months into the 12-month grants. Semi-
structured interviews were conducted with three to nine
key informants per system and with ACS primary care
managers. Leadership at each system identified all staff in-
volved in project implementation and evaluators attempted
to interview all identified staff. In some cases, interviews
were conducted with two to three staff simultaneously, de-
pending on staff availability, but the majority of interviews
were conducted one-on-one. Key informants included ex-
ecutive directors, chief medical officers, information tech-
nology staff, quality improvement coordinators, medical
assistants, nurses, community health workers, and patient
navigators. A total of 52 interviews were conducted with 61
individuals for an average of six interviews per system.
Data collection instruments
Interview guides Interview guides were developed by
ACS evaluation staff, with tailoring for category of re-
spondent (i.e., leadership, staff, and ACS primary care
managers). The guides did not directly address CFIR
constructs but focused on implementation with both
general and specific questions surrounding implementa-
tion. Interview topics included intervention selection,
start-up activities, implementation details (e.g., imple-
menters, training, implementation processes), challenges
and facilitators to implementation, policy and practice-
level changes, staffing structure, partnerships, and sus-
tainability. See Table 1 for a list of interview questions
by topic. The interviews averaged 60 min in length and
were audio recorded and transcribed verbatim.
Progress reports Each system worked with local ACS
support staff, to varying degrees, to develop annual goals
and screening targets for their program. However, how
such goals were developed varied. Some were based on
baseline screening data; some had difficulty calculating their
baseline screening rates and determined their goals based
on professional judgment. Each system submitted quarterly
reports to ACS through an online tracking tool as well as a
final report. Grantees provided data to regional ACS
primary care managers who then entered it into a central-
ized database. Data included screening information (screen-
ing targets, numbers screened) and intervention-specific
data (number of contacts made though one-on-one educa-
tion, outreach and client reminders).
Secondary data analysis
Implementation level determination
We categorized the nine systems into high-, medium-,
and low-performing systems based on data collected from
the quarterly and final reports as well as the process and
qualitative data collected from the site visits. Each system
implemented a combination of patient- and provider-
oriented strategies, with plans evolving as the grant year
unfolded. To facilitate cross-system comparisons, we ex-
amined the extent to which client reminders were imple-
mented. Client reminders was the only EBP implemented
by all nine systems. We also examined the extent to which
the systems attained their quantitative screening targets.
Given the variable quality of reporting, we also included
qualitative indicators of success in our analysis including
potential sustainability of selected EBPs as described by
the key informants at each site. Table 2 provides a brief
description of each of the nine systems and summarizes
how they performed on these dimensions.
Qualitative data analysis
Each safety net system is considered a case in our ana-
lysis. We employed a largely deductive approach using a
codebook based on the CFIR constructs and definitions.
All analysts (N = 6) participated in testing the codebook
by coding two transcripts from one system and through
multiple research team meetings to refine and reach
consensus on code definitions and use. Analysts were
instructed to adhere strictly to the definitions and apply
codes without making inferences from the data. After
the codebook was finalized, the qualitative data analysis
was conducted in three phases.
The goal of the first phase was to organize the data with
CFIR codes and build the foundation for case-based ana-
lysis [29]. A pair of analysts coded each transcript inde-
pendently with CFIR codes and then met to resolve
discrepancies. After consensus was reached, final codes
were applied to the transcripts using NVivo 10. For each
case, an analyst was designated as a case “expert” who
coded all transcripts of that case and reviewed its project
proposal and evaluation reports. All analysts kept brief
memos for each transcript, which were compiled by the
expert for each case to facilitate future analyses [30].
The goal of phase two was to distill the data into brief
summaries for each CFIR construct and for each case. We
generated a report via NVivo containing all relevant text
units for each construct from all transcripts within each
case. From this report, we created summaries and applied
ratings for each construct first at the individual transcript
level and then at the case level. We applied a rating system
with two dimensions: magnitude and valence. “Valence”
refers to the construct’s influence on implementation of
EBPs—positive, negative, mixed, or largely descriptive with
no valence (see Table 3). At the individual transcript level,
valence was determined by respondents’ accounts related
to the specific construct. At the case level, we also took
into account whether or not the respondents in different
transcripts agreed with each other in terms of the con-
structs’ influence on implementation. “Magnitude” refers
to the extent to which the constructs were discussed. At
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the individual transcript level, “magnitude” was represented
by the total number of mentions of a construct in a tran-
script and the proportion of text coded with that construct
per transcript. At the case level, the “magnitude” was deter-
mined using two methods that complemented each other.
It was first determined by multiplying the number of ex-
cerpts coded with a construct within a case by the propor-
tion of transcripts that were coded with a construct per
case. We also assessed “magnitude” based simply on the
proportion of transcripts within a case that were coded
with a construct (i.e., none = 0 %, few = 1 = 25 %, some =
26–50 %, many = 51 = 75 %, most = 76–99 %, all = 100 %).
The case expert summarized the following information
for each construct in a case-specific matrix with con-
structs as rows and transcripts as columns: (1) a brief
summary of how this construct manifested in a particular
transcript, (2) a magnitude and a valence rating of the
construct’s influence on implementation of EBPs in a par-
ticular transcript. Once this step was completed for all
transcripts within each case, the case expert reviewed the
information across all the transcripts and aggregated them
to the case level for each CFIR construct with a case-level
summary and ratings. The case expert also composed a
case narrative identifying the most salient constructs that
affected implementation. Both the matrix and narrative
for each case were reviewed by a secondary analyst. Dis-
crepancies were noted by the second analyst and resolved
through discussion.
The goal of phase three was to identify patterns of in-
fluence on implementation for each CFIR construct
across all nine cases [29]. We sought to identify CFIR
constructs that distinguished high-, medium-, and low-
performing cases. To achieve this goal, the case sum-
maries and ratings from phase two were imported into a
case-ordered matrix in which cases were listed by level
of implementation [31]. Two analysts independently
reviewed the magnitude and the valence of all constructs
across nine systems to identify distinguishing patterns
across high, medium, and low-performing systems. Pat-
terns were then confirmed by a third analyst. Table 4
Table 1 Key informant interview guide questions
Topic Interview questions
Clinic characteristics About how many patients does your clinic serve
annually? About how many over the age of 50?
Please describe services provided by the clinic.
Is your clinic part of a larger health network?
ACS relationship Describe your organization’s relationship with
ACS prior to working with this project. What
factors influenced your decision to work with
ACS on this grant? How often did you meet/
talk with ACS staff during the project period?
What type of training or TA did ACS staff
provide? What type of training or TA would be
useful to assist you in implementing this type
of intervention in the future?
Intervention
selection
Were you involved in the decision-making
process for choosing these interventions?
Can you describe in detail what activities you
are doing with the ACS project? How did you
decide to implement these particular
intervention strategies for this grant program?
Who was involved in that decision? What factors
influenced you to select these intervention
strategies? If you had already been doing any
of these interventions before the grant program,
for how long? What factors influenced you to
originally implement this intervention?
Intervention
implementation
Please describe the steps you took to implement
the intervention. What staff are involved in
implementation? What are their titles and general
responsibilities? What were their responsibilities
related to the intervention? About what percentage
of their time would you say is dedicated to the
intervention? What training did staff receive prior
to implementing the intervention? What type of
ongoing training/meetings did you have during
the project period to assess progress? Are community
health workers involved in implementation? If this is a
new intervention, how long did it take to fully
implement the intervention? If this is an existing
intervention, how long did it take to implement the
project specific activities? Please describe your process
for referring individuals for screening. What were
some of the challenges in implementing the
intervention? What steps did you take to overcome
the challenges? What were some factors that helped
you implement the intervention?
Program goals Were you involved in developing the program goals
and target numbers? What are your target number of
screenings and individuals educated for the grant
program? How did you determine the target
numbers? Did you provide baseline screening referral
data to ACS prior to this project? After starting this
project? How did you determine your baseline? Were
you able to reach your education goals? Screening
goals? If not, what factors do you think prevented
you from reaching your goals? If so, what factors
helped you reach your goals? Do you know the
targeted number of screenings and individuals to be
educated for the project?
Data collection How do you work with ACS to report data on
education and screening numbers? How do you
usually track these types of activities? What
difficulties did you experience in providing the
data to ACS? What would make it easier for you
to report data to ACS?
Table 1 Key informant interview guide questions (Continued)
Electronic health
record utilization
Does your clinic use an electronic health record
system? How do you use this EMR to obtain
information on colorectal cancer screening? With
regard to the project, to what extent did you
utilize EMR? Were there any particular challenges
utilizing EMR to support the intervention?
Sustainability Will the partnership with ACS continue after the
project ends? If so, in what ways? After the
project is over, will the work implemented as a
result of the project continue? If so, in what
ways? Were any staff hired for the project? Will
they remain on staff? With regard to the project,
are there plans to advance the work
implemented? If so, please explain.
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presents results from the intervention characteristics
domain as an example of our approach (see additional
tables for the other domains).
Results
Table 2 briefly describes the nine systems and presents
implementation outcomes by system. Six systems were
FQHCs or FQHC look-alikes. The other three systems
were large and complex health systems with varying pri-
mary care arrangements (e.g., FQHC partner, or affili-
ated primary care clinics). One of these was an urban
Table 3 Construct rating criteria
Rating Criteria
+ Facilitated the implementation of intervention
− Hindered the implementation of intervention
+/− Posed both positive and negative impact (mixed effects) on
implementation
D Purely descriptive, no impact upon implementation described















System A (n = 9) CRC (FIT) FQHC (medium) Exceeded Exceeded High
13,380
(161 % of goal)
FIT: 2130
(128 % of goal)




(480 % of goal)





(140 % of goal)
3500




System C (n = 7) CRC (colonoscopy) University health system
with FQHC partner








System D (n = 6) CRC (FIT) FQHC (large) Exceeded Exceeded Medium
8680
(2480 % of goal)
260
(115 % of goal)
Sustainability unclear
—vague discussion




(352 % of goal)
970 Sustainability unclear
—will need to scale
back outreach
System F (n = 7) Breast (mammography) FQHC (small) No target Exceeded Medium
200 1180





System G (n = 5) Breast (mammography) Regional health system
(large)
No target Not met Low
350 250 Sustainability unlikely for
screening—need funding
& no concrete actions taken
System H (n = 3) Breast and colorectal
(mammography and
colonoscopy)
FQHC (medium) No report No report Low
Sustainability mixed—EMR
changes sustainable, outreach
will be scaled back
System I (n = 6) Breast (mammography) FQHC look-alike (small) No target Not met Low
180 <5 Sustainability unclear-limited
practice changes to sustain
aLarge >40,000 patients; medium 15,000 to 40,000 patients, small <15,000 patients
bFrom final reports
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community health system (system B), another was a
large university-based health system (system C), and the
third was a large regional health system (system G).
Across the nine systems, four served over 40,000 pa-
tients (systems B, C, D, G), three served 15,000 to
40,000 patients (systems A, E, H), and two were rela-
tively small with fewer than 15,000 patients (systems F
and I). Four of the systems focused on EBPs for colorec-
tal cancer screening (systems A, B, C, D), four on breast
cancer screening (systems E, F, G, I), and one on both
types of cancer (system H). The systems rated as having
high implementation levels (systems A, B, C) completed
more than 2000 screening tests in the funded grant year.
Those rated as having medium implementation levels
(systems D, E, F) reported more than 250 but fewer than
1500 screenings, combined with at least modest success
in implementing client reminders. Systems with low
levels of implementation (systems G, H, I) reported 250
screenings or fewer, and modest or few client reminders.
Intervention characteristic domain
Among the eight constructs within this domain, we ob-
served distinguishing patterns for two constructs: adapt-
ability and trialability.
Adaptability
Adaptability, or the degree to which an intervention can
be tailored to better fit the organizational context, was
described as a positive influence in eight systems. The
magnitude of influence, however, was stronger in the
high-performing systems relative to the low-performing
systems (see Table 4). In the three higher-performing
systems, adaptations were made to the EBP delivery
models after initial implementation based on lessons
learned from early delivery challenges. For example, sys-
tem A changed the implementer model (from reception-
ist to medical assistants) for carrying out patient
reminders to increase efficiency and increase privacy for
patients. System B changed the frequency and timing of
Table 4 System-ordered matrix of magnitude and valence of intervention characteristics constructs by level of implementation
Construct High level of implementation Medium level of implementation Low level of implementation Distinguishing
Intervention characteristics A B C D E F G H I
Intervention source
Magnitude Some Some Few None Few Some None None Few No
Valence +/− 0 0 ~ + + ~ ~ +
Evidence strength and quality
Magnitude Few Some Some None None Some Some None Few No
Valence + 0 + ~ ~ + + ~ +
Relative advantage
Magnitude Some Some Few Some Many Some Few Some None No
Valence + +/− + + +/− + + + ~
Adaptability
Magnitude Some Many Some None Few All Few Some Some Yes
Valence + + + ~ + + + + +
Trialability
Magnitude Some Some Few None Some Some None None Few Yes
Valence + + 0 ~ + + ~ ~ 0
Complexity
Magnitude Some Some Few Some Few Few Few None None No
Valence +/− − − − − 0 − ~ ~
Design quality and packaging
Magnitude Some Some Many None Few Some Few Many Few Borderline
Valence +/− + + ~ + + − +/− +
Cost No
Magnitude None None Many Some Few Few Few Some Few
Valence ~ ~ + − 0 0 0 − 0
Notes on magnitude: none = 0, few = 1 = 25 %, some = 26–50 %, many = 51 = 75 %, most = 76–99 %, all = 100 % of transcripts in each system that mentioned the
construct. Notes on valence: ~ = not applicable, 0 = descriptive only, + = positive, − = negative, +/− =mixed
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the mailing and phone calls for conducting patient re-
minders to decrease the frequency of missed colonos-
copy appointments, modified data-capturing tools, re-
vamped how to deliver education on colonoscopy prep-
aration, and eliminated extra steps for patients during
the screening process:
“… at one point a patient would go to tell them on the
sixth floor that they had arrived, but then go down to
the second floor to register at the cashier, and then go
back to the sixth floor to say, okay, I checked in, now
what? It was – so we try to cut all the extra steps and
just make one smooth flow.”
Two of the three medium-performing systems dis-
cussed adaptation. System E’s community health worker
came up with creative ways to deliver patient education.
In system F, comments about adaptation described how
certain features of the intervention could be adapted,
such as use of appropriate languages to educate patients
and supplementing the current electronic medical rec-
ord (EMR) system with other tracking tools. In contrast,
there was less discussion of adaptation in the three low-
performing systems. Respondents from systems G and I
discussed patient education materials. A respondent
from system H simply expressed appreciation for being
able to adapt.
While adaptation manifested positively across sys-
tems, the main differences across systems lied in the
magnitude to which adaptation was discussed and the
types of adaptation being made. Detailed descriptions
of adaptations were shared in high- and medium-
performing systems and most of the adaptations were
made to the delivery of the intervention. The lower-
performing systems described fewer changes, and
when they did, changes were primarily made to
educational materials, thus suggesting that adaptabil-
ity, or the actual adaptation of EBPs, influences im-
plementation outcomes.
Trialability
Trialability, or the ability to pilot test before full-scale
implementation, was discussed in six systems; three sys-
tems did not refer to this construct. Four out of six ac-
counts of this construct were positive and two were
descriptive (Table 4). The high-performing systems en-
gaged in more discussion of trialability than medium-
and low-performing systems, as reflected in the higher
magnitude scores. All high-performing systems tried at
least one pilot to figure out the best model for their sys-
tem. For example, system A selected a clinic location
that was viewed as ideal for piloting and determining the
best approach to engage and remind patients about the
fecal immunochemical test (FIT):
So it’s kind of a fertile ground to play things out……
we’re big enough, so just a great place to have pilots.
Two of the medium-performing systems also used pi-
lots. System E pilot tested the role of outreach workers
and learned it was a struggle to schedule outreach events
at churches and local pharmacies. System F tried different
workflow procedures, such as communicating to providers
via EMR pop-ups. Only one system from the lower-
performing group (system I) mentioned trialability, and
they described the entire CHANGE program as a pilot
program with a lot of challenges, while also helping them
identify areas for improvement. Because the higher-
performing systems described trialability in significant de-
tail and it was not discussed or only mentioned in general
terms in the lower-performing systems, trialability appears
to have an important influence on implementation. This
construct was closely associated with adaptability, given
that adaptations were often made after trying a particular
approach to implementation.
Outer setting domain
A large majority of respondents across all nine cases dis-
cussed patient needs and resources and cosmopolitanism
as important factors influencing the implementation of
EBPs (see Additional file 1: Table S1). However, discus-
sion of these and other outer setting constructs did not
vary noticeably by level of implementation.
Inner setting domain
Three inner setting constructs clearly distinguished sys-
tems by implementation outcomes (Additional file 1:
Table S2): leadership engagement, tension for change,
and access to information and knowledge.
Leadership engagement
Leadership engagement, a sub-construct under readiness
for implementation, was referenced in all systems. The
accounts of this construct described how leaders were
involved in the implementation of the EBPs, and in-
cluded establishing program goals and individual roles,
providing ongoing support and guidance, providing dir-
ect services for patients, and monitoring progress with
feedback to staff. Eight out of nine systems described
this factor as exerting a positive impact. However, the
magnitude of influence appeared higher among the
high-performing systems. In the high-performing sys-
tems, all respondents shared positive views. For example,
in system A, both the front-line navigators and staff
leaders thought that the program director played a key
role in pulling things together to make the CHANGE
program happen:
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“So she (program director) was the main driver of the
project, and …kind of showed us what the – how we
would benefit from this, how important it is.”
System B described how executive-level leaders were
at the table asking questions and ensuring accountability
through reporting of outcomes. Leadership engagement
was mentioned less frequently across the medium- and
low-performing systems, with fewer concrete examples
of how leaders were actively engaged.
These patterns were repeated in the initial phases of the
implementation process. In all high-performing systems,
both the leadership and key implementers were able to
present the CHANGE program or the EBPs in a way that
was relevant and useful, which helped them earn buy-in
from providers and staff for actual implementation. Such
communication typically occurred during staff or leadership
meetings, in which project leaders presented the benefits
and rationale for the program with supporting data and evi-
dence. In contrast, two of the lower-performing systems
expressed uncertainty about the project at the onset rather
than enthusiasm. Because the discussions of leadership en-
gagement varied both in terms of magnitude and depth
across performance groups, combined with varying ap-
proaches to “selling” the program, leadership engagement
appears to have an important influence and distinguish im-
plementation outcomes.
Tension for change
Tension for change, or the degree to which stakeholders
perceive the current situation as intolerable or needing
change, was discussed in eight out of nine systems. The
account of this construct was often described in the con-
text of identifying gaps in quality measures (e.g., low
cancer screening rates), deficiencies in reaching patients
(e.g., existing outreach only reached a limited number of
patients), and problems with completing cancer screen-
ings (e.g., high no-show rates for colonoscopies or low
return rate of FIT kits). Such gaps and problems were
often identified through quality improvement efforts
and were frequently reported as the rationale for
participating in the CHANGE program. The construct
was most commonly discussed (with higher
magnitude) in the high-performing systems with de-
tailed and specific descriptions of why the program
was needed. For example, a respondent from system
B shared how the program addressed a specific need
identified by providers:
“The oncologist and GI specialists approached us,
this is a need that …. We’re having a lot of
no-shows for colonoscopies. Can you guys help us?
Usually when a specialist approaches and tells you,
it’s real.”
Respondents from the medium-performing systems
also discussed tensions for change. System D respon-
dents discussed challenges associated with getting accur-
ate data on screening rates given the need to get reports
back from specialists and enter them into EMR in a way
that allows for report generation. System E discussed
their low screening rates relative to neighboring FQHCs.
In contrast, lower-performing systems either did not dis-
cuss any tension for change or made general observa-
tions about how the program provided an opportunity
to address cancer. This pattern suggests that identifying
specific deficiencies in measures and practice might have
created more tension for change, leading to increased
momentum for implementing the EBPs.
Access to information and knowledge
Access to information and knowledge refers to the ease
of access to information about the intervention and how
to incorporate it into organizational processes. Descrip-
tions centered on training and educational resources
available for the appointed implementers of the
CHANGE program. Most accounts were positive among
the high-performing systems, with adequate trainings for
staff often cited as key to successful implementation.
Training was not discussed as frequently in medium-
and lower-performing systems and tended to be descrip-
tive. Negative perspectives referred to a lack of consen-
sus on training needs and the absence of written plans
or protocols to guide implementation. For example, a re-
spondent from system H described:
“So there was no set process. There wasn’t a written
down set process, which was – it made it more
difficult……when you’re on your own, it can be kind of
overwhelming sometimes to make sure that you hit
everything that you need to do.”
Given the notable differences in access to information
and availability of training in the higher-performing sys-
tems relative to the lower-performing systems, it appears
that this construct facilitated successful implementation.
This construct also appeared to be highly related to lead-
ership engagement given the knowledge and information
for implementation was most often initiated and pro-
vided by organizational leaders.
Individual characteristics domain
Constructs from the individual characteristics domain
were not often discussed across the nine systems (Add-
itional file 1: Table S3). Knowledge and beliefs about the
intervention and personal attributes were discussed most
commonly, but none of the constructs from this domain
differentiated systems by levels of performance.
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Implementation process domain
Respondents discussed the process of implementing the
EBPs in depth, with substantive discussions focused on
planning, executing, and reflecting and evaluating. Despite
the salience of key constructs within this domain, only for-
mally appointed internal implementation leaders varied by
level of implementation (Additional file 1: Table S4).
Engaging formally appointed internal implementation
leaders
Formally appointed internal implementation leaders, a
sub-construct under engaging, was discussed by all nine
systems. Implementation leaders were typically patient
navigators, health educators, nurses, or medical assis-
tants who implemented the major tasks of the CHANGE
program in each system. High- and medium-performing
systems tended to discuss the importance of these roles
more than lower-performing systems. The magnitude of
influence of this construct was higher among high- and
medium-performing systems. For example in system A,
the medical assistants were appointed as primary imple-
menters of the CHANGE program to increase CRC
screening, which improved workflow and required less
direct involvement of the providers:
“We basically taught the MAs how to do the bulk of
the work and then when they got to either a question
or at that point at all, once – if they had a FIT test
and it was obvious it was done in the last year, then
the MA knew not to order it. But if there was no FIT
test, the MA ordered it.”
Systems B and C also described the roles of implemen-
tation leaders in depth, with respondents from both sys-
tems describing the specific roles and responsibilities of
patient navigators in EBP implementation. In contrast, re-
spondents from system D did not discuss a single point
person and system E shared that no new staff were hired,
but clinical leadership were very engaged in the entire
intervention planning and implementation process.
Lower-performing systems tended to describe implemen-
tation leaders less often and in neutral terms, or in the
case of system G, acknowledging the challenges associated
with not having a dedicated point person:
“But we knew going in from the beginning that it was
something that was going to be a challenge because we
didn’t have a dedicated staff member. We couldn’t
take somebody out of clinical time to send them out to
the community.”
These differences in the presence of a formally
appointed implementation leader across performance
levels, combined with the more frequent and detailed
discussions in higher-performing systems, suggest that
this construct differentiates levels of implementation.
Discussion
This study examined factors influencing implementation
of EBPs to promote breast and colorectal cancer screen-
ing in safety net systems using CFIR. One of our main
findings was that leadership engagement clearly distin-
guished high-, medium-, and low-performing systems.
Our findings are consistent with a number of studies
that have identified leadership engagement as key to suc-
cessful implementation [32–34]. Using similar methods
in a study focused on implementation of a weight loss
program into five VA systems, Damschroder and Lowery
found that leadership engagement was strongly associ-
ated with successful implementation; leaders allocated
staff time, solved problems, obtained needed resources,
and kept the program visible [14]. In contrast, a recent
study on implementation of internet-based patient-
provider communication by Varsi and colleagues used
similar methods and did not find leadership engagement
to be consistently related to implementation [25]. Such
variance in the influence of leadership across different
study settings suggests that while leadership engagement
is generally considered key to success, how to maximize
leaderships’ positive influence in implementation might
depend on the nature of the setting and EBP.
In addition to leadership engagement, formally appointed
implementation leaders strongly distinguished level of im-
plementation in our study. Within the VA study, most of
the systems had a strong coordinator, and thus, formal im-
plementation leaders did not distinguish between systems
due to lack of variability [14]. In the Varsi et al. study, for-
mally appointed implementation leaders weakly distin-
guished level of implementation [25]. Our findings are
consistent with a qualitative study by Martinez-Gutierrez et
al., which found designation of non-physician staff to do
specific prevention activities had a major impact on cancer
screening rates in a single FQHC system [35]. Taken to-
gether, our findings on leadership engagement and formally
appointed implementation leaders suggest that successful
implementation of EBPs requires leaders at multiple levels
to function with high capacity. Leaders at the executive
level should be highly engaged in goal setting, establishing
roles, getting buy-in from providers, providing training, and
monitoring progress, while front-line implementation
leaders are crucial in day-to-day operations and pilot test-
ing, as well as identifying inefficiencies in current processes
and suggesting changes for program delivery [36].
We identified four additional constructs that distin-
guished levels of implementation across systems; two of
these constructs were from the intervention characteris-
tics domain: adaptability and trialability. Higher-
performing systems in our study gave detailed accounts
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of how they adapted or tailored the intervention to fit
their setting; systems that struggled with implementation
tended to describe adaptations to educational materials
rather than clinic flow or processes. Higher-performing
systems in our study also conducted pilot studies of the
EBPs to inform broader implementation, often using a
quality improvement process. Interestingly, neither of
these constructs were distinguishing factors in the
Damschroder and Lowery study due to lack of variation
across systems for adaptability, and because none of the
systems conducted a trial of the intervention. Trialability
was a distinguishing factor in the Varsi et al. study [25].
Overall, our findings on the importance of various as-
pects of the intervention itself are consistent with the
large body of research on diffusion of innovations and
related studies that have examined how intervention
characteristics influence implementation [11, 34, 37, 38].
Two additional inner setting constructs distinguished
levels of implementation in our study, including tension
for change and access to information and knowledge.
Similar to prior studies, systems with higher levels of im-
plementation tended to describe a concrete need for the
program [25]. In our study, needs tended to be identified
through quality improvement efforts showing room for
improvement in screening rates or challenges with exist-
ing screening approaches. Access to information and
knowledge usually related to training opportunities pro-
vided by leadership in our study, with high-performing
systems describing trainings more often and in greater
detail. Training was not available as part of the VA im-
plementation project, and training was viewed as ad-
equate in all of the systems in the Varsi et al. study [14,
25]. Other studies have similarly identified training of
key staff as important for implementation [16, 33]. With
respect to the other inner setting constructs, Sohng et
al. found that communication and resource availability
were positively associated with the likelihood of EBP im-
plementation for cancer screening [39]. We did not find
these constructs to distinguish levels of implementation,
in large part because network and communication ap-
peared to have similar influence (in terms of magnitude
and valence) across the nine systems.
Another notable finding from our study is that, despite
variability among the nine safety net systems in terms of
size, population served, and organizational infrastructure,
none of these factors differentiated implementation levels.
In a systematic review that included cancer screening ef-
forts in both FQHCs and other health organizations,
Anhang Price et al. identified organizational factors and
processes that helped to increase cancer screening rates at
each step in the cancer screening process [36]. Interest-
ingly, similar to our findings, organizational structures,
such as size and type, were not associated with screening
rates. Rather, improvements in screening rates were
largely driven by organizational strategies to (1) limit the
number of interfaces across organizational boundaries; (2)
recruit patients, promote referrals, and facilitate appoint-
ment scheduling; and (3) promote continuous patient
care. These organizational processes were similar to those
described in our study and correspond to the roles of lead-
ership and formally appointed implementation leaders,
which were both distinguishing factors for implementa-
tion success.
Our study employed a slightly different rating approach
than the rating system proposed by Damschroder and
Lowery and the CFIR guide [14]. The “valence” dimension
in both approaches was essentially the same and charac-
terizes the influence of CFIR constructs as positive,
negative, mixed, and neutral/descriptive. The “strength”
dimension in Damschroder’s and Lowery’s rating system is
generally comparable to our “magnitude” dimension.
However, their “strength” rating system incorporated sev-
eral distinct factors, including the level of agreement
among participants, strength of language, and use of
concrete examples. We used level of agreement among
participants to inform our “valence” dimension (e.g., did
participants agree on whether the construct had a positive
or negative influence), and we found it challenging to as-
sess strength of language in a systematic manner with
multiple respondents within each case and multiple men-
tions of constructs within each transcript. Thus, we chose
to assess magnitude as described above, which factored in
the extent to which a particular construct was discussed
across respondents from each site.
Limitations
Several limitations should be considered when assessing
the performance of each system and our related findings.
The first limitation is related to the accuracy of the
quantitative measures of completed screenings, which
might in turn impact the accuracy of implementation
outcomes. The participating systems used a variety of
methods to specify their screening targets, and to some
extent these were arbitrarily determined. Targets were
not set using a standardized formula, and grantees were
not provided specific criteria for targets. Some systems
set goals using baseline data from previous years but
baseline data did not always reflect the system’s actual
performance due to reporting and EMR system errors.
All these limitations, however, reflect the reality of im-
plementation challenges in resource-constrained safety
net health care settings. Nevertheless, it does have impli-
cations for the validity of our implementation outcome
categories, despite our efforts to triangulate across mea-
sures. Second, the systems that performed better in
terms of implementation outcomes tended to be ad-
dressing CRC rather than breast cancer. This may reflect
that systems ready to take on CRC were with higher
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capacity given that addressing CRC within FQHCs is
relatively new compared to efforts to increase breast
cancer screening. Third, the interview guide was devel-
oped to answer ACS’s evaluation questions, and was not
informed by CFIR. As a result, some of the constructs
that did not emerge as salient may have been salient if
asked about explicitly. On the other hand, the interview
guides were designed to identify barriers and facilitators
to implementation with mostly general questions not
specifically addressing CFIR constructs. Therefore, the
themes that emerged from the responses to these gen-
eral questions were in essence perceived by the partici-
pants to be the most salient factors. Though the study
was not originally designed to test CFIR, the fact that so
many of these emergent factors identified in this post
hoc, deductive fashion were consistent with CFIR do-
mains and constructs could serve to validate the utility
of CFIR [34]. As a meta-theoretical framework, CFIR
was developed to serve as a comprehensive typology of
factors influencing implementation, to compare results
across contexts and to identify new theoretical develop-
ments. A recent systematic review of the use of CFIR
found that the majority of published studies were using
CFIR to guide data analysis alone [40]. Our study will
add to this repository of studies that could facilitate
cross-context comparisons. Future research could com-
pare findings between studies using CFIR to guide data
analysis alone and those using CFIR throughout the data
collection and analysis process.
Conclusions
Overall, our study suggests that despite the resource-
constrained environment, with moderate support, such
as the grants and technical assistance from ACS, safety
net health systems can successfully implement EBPs to
increase cancer screening. While size, patient popula-
tion, and organization structure did not distinguish im-
plementation success, the key factors to successful
implementation may include strong leadership and
front-line implementation leaders, adequate training and
information, and organizational processes to identify de-
ficiencies, pilot test new ideas, and make adaptations ac-
cordingly. Future interventions aiming to increase
cancer screening or implement other EBPs in similar
safety net settings could consider intervening on these
factors while designing their efforts. Practitioners imple-
menting EBPs could consider focusing their resources
on developing implementation strategies that target
these factors, such as training designated implementa-
tion leaders and setting up organizational processes to
provide information and ongoing feedback to those
involved in day-to-day implementation. Our study
also contributes to the growing body of research on
CFIR. As described by Damschroder and Lowery [14],
contributing to a repository of findings will enable
the field to begin to understand which constructs have
predictive ability, which can be manipulated for better im-
plementation outcomes, and the situations in which spe-
cific constructs are salient. Our study also provides
suggestions for exploring relationships among CFIR con-
structs which will aid in future studies of construct validity.
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